UPI.V - Breakout. 1-min rapid COVID-19 tests and much more.
Updated
UPI is a fundamentally strong company with 10M in year revs and only 22M mkt cap.
They're selling various COVID-19 detection tech and are also in air sanitation business. Today's news adds to their portfolio nicely:
Universal PropTech Inc. Invests in and Secures defined Agency Rights for ISBRG Corp.'s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute
Toronto, Ontario--(Newsfile Corp. - February 18, 2021) - Universal PropTech Inc. (TSXV: UPI) ("UPI" or the "Company") is pleased to announce that it has completed an investment in ISBRG Corp. ("ISBRG") for a minority interest, and secured agency rights to their SpotLight-19© Technology.
ISBRG is a data analytics company which has developed the SpotLight technology platform designed to generate comprehensive health care data non-invasively within seconds at a nominal incremental cost per test. SpotLight-19© is non-invasive, and ISBRG is undertaking trials to determine efficacy in detecting Covid-19. In addition to its minority investment, UPI will act as the exclusive sales agent for the SpotLight-19© technology and other future platform offerings for the government and education sectors in Canada.
They're selling various COVID-19 detection tech and are also in air sanitation business. Today's news adds to their portfolio nicely:
Universal PropTech Inc. Invests in and Secures defined Agency Rights for ISBRG Corp.'s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute
Toronto, Ontario--(Newsfile Corp. - February 18, 2021) - Universal PropTech Inc. (TSXV: UPI) ("UPI" or the "Company") is pleased to announce that it has completed an investment in ISBRG Corp. ("ISBRG") for a minority interest, and secured agency rights to their SpotLight-19© Technology.
ISBRG is a data analytics company which has developed the SpotLight technology platform designed to generate comprehensive health care data non-invasively within seconds at a nominal incremental cost per test. SpotLight-19© is non-invasive, and ISBRG is undertaking trials to determine efficacy in detecting Covid-19. In addition to its minority investment, UPI will act as the exclusive sales agent for the SpotLight-19© technology and other future platform offerings for the government and education sectors in Canada.
Note
A series of interesting tweets from UPI partner LuminUltra:"We're proud to announce that @UPropTech
will use our rapid #SARSCoV2 surface testing solution across more than 2,000 facilities in Canada — giving their customers insight into the health of their facilities and peace of mind."
"We're proud to announce that Toronto Pearson International Airport will be using our game-changing rapid #COVID19 qPCR clinical testing solution on-site, testing volunteer employees and passengers."
The chart looks ready for another leg up!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.